Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Novelion (NVLN.TO)

Novelion (NVLN.TO)

0.00
-0.00 (0.00%)
52 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
WEAK BUY

Novelion(NVLN.TO)

May 21, 2002
Volatile. Not a fan of biotechs. Highly regulated by FDA and insurance companies who approve drugs for coverage. Only have a small portion of your portfolio into Biotechs.
Photo of David BaskinDavid BaskinUnlock Rating
$18.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

May 15, 2002
Dropped in price because of inaccurate press release on a competitors trial run. A good price.
Photo of Mike WeirMike WeirUnlock Rating
$19.47

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

May 08, 2002
In good shape, but can wait for awhile.
Photo of Richard StoneRichard StoneUnlock Rating
$19.70

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Novelion(NVLN.TO)

May 01, 2002
Having some problems getting approvals. Weak pipeline.
Photo of Mark Jackson, CFAMark Jackson, CFAUnlock Rating
$20.85

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Apr 18, 2002
At a good price. Starting to see some good numbers.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$24.70

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Apr 12, 2002
Has had problems getting approval from regulatory bodies.
Photo of David BaskinDavid BaskinUnlock Rating
$21.76

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Apr 11, 2002
Has a lot of cash. Earnings may drop. Developing a pipeline. At a good price.
Photo of John ZechnerJohn ZechnerUnlock Rating
$21.62

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Mar 12, 2002
Good product. New management should be good. Good pipeline.
Photo of Mark Jackson, CFAMark Jackson, CFAUnlock Rating
$30.46

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Novelion(NVLN.TO)

Mar 06, 2002
(Was a top pick on Dec 5 up 18%) Still likes. Down because of some re-imbursement concerns.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$31.92

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Feb 28, 2002
Near its low. Fair Market Value = $24/25.
Photo of Ross HealyRoss HealyUnlock Rating
$28.60

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Feb 19, 2002
Got caught up in big tech correction. Quality company, but volatile.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$28.85

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Feb 18, 2002
Good core holding. Biotechs can be volatile.
Photo of Richard StoneRichard StoneUnlock Rating
$28.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Feb 12, 2002
Has been a one trick pony, but now has some possible cancer treatment products coming out in 2/3 years. At a good price.
Photo of Ted MacklinTed MacklinUnlock Rating
$29.13

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Feb 07, 2002
High P/E. Product is not a major money maker.
Photo of David BaskinDavid BaskinUnlock Rating
$26.63

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Feb 06, 2002
Valuation is high. Good product.
Photo of Bob StodgellBob StodgellUnlock Rating
$28.75

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 106 to 120 of 190 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video